Cor Vasa 2006, 48(4):128-130 | DOI: 10.33678/cor.2006.043

Nemocní po akutním infarktu myokardu - co více můžeme nabídnout?

Michael Aschermann, Aleš Linhart
II. interní klinika kardiologie a angiologie, Všeobecná fakultní nemocnice a 1. lékařská fakulta Univerzity Karlovy, Praha, Česká republika

Published: April 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Aschermann M, Linhart A. Nemocní po akutním infarktu myokardu - co více můžeme nabídnout? Cor Vasa. 2006;48(4):128-130. doi: 10.33678/cor.2006.043.
Download citation

References

  1. Widimský J, Vaněk P, Juráň F, Lánská V. Stav kardiovaskulární farmakoterapie u nemocných po infarktu myokardu a/nebo revaskularizaci myokardu v roce 2005 v České republice. Vývoj za 5 a 10 let. Cor Vasa 2006;48: 135-41. Go to original source...
  2. Smits AM, van Vliet P, Hassink RJ, et al. The role of stem cells in cardiac regeneration. J Cell Mol Med 2005; 9:25-36. Go to original source...
  3. Schwartz Y, Kornowski R. Progenitor and embryonic stem cell transplantation for myocardial angiogenesis and functional restoration. Eur Heart J 2003;24:404-11. Go to original source... Go to PubMed...
  4. Smits PC, Van Geuns RJ, Poldermans D, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure. J Am Coll Cardiol 2003;42:2063-9. Go to original source...
  5. Kamínek M, Meluzín J, Groch L, et al. Úprava infarktového ložiska autologní transplantací mononukleárních buněk kostní dřeně: role kvantitativního Tc-99m-MIBI SPECT a F-18-FDG PET při monitorování léčby. Cor Vasa 2005;47:203-7.
  6. Meluzín J, Mayer J, Groch L, et al. Regenaration of a damaged myocardium by autologous bone marrow cell transplantation. Cor Vasa 2004;46:537-43.
  7. Aschermann M, Aschermann O. Kmenové buňky po akutním infarktu myokardu. Cor Vasa 2004;46:355-7.
  8. Aschermann M. Buněčná terapie pro regeneraci myokardu. Cor Vasa 2005;47:171-5.
  9. Orlic D, Hill JM, Arai AE. Stem cells for myocardial regeneration. Circ Res 2002;91:1092-102. Go to original source...
  10. Balsam LB, Wagers AJ, Christensen JL, et al. Haematopoetic stem cells adopt mature haematopoetic fates in ischemic myocardium. Nature 2004;428:668-73. Go to original source... Go to PubMed...
  11. Deten A, Volz HCh, Clamors S, et al. Hematopoetic stem cells do not repair the infarcted mouse heart. Cardiovasc Res 2005;65:52-63. Go to original source... Go to PubMed...
  12. Chachques JC, Duarte F, Cattadori B, et al. Angiogenic growth factors and/or cellular therapy for myocardial regeneration: A comparative study. J Thorac Cardiovasc Surg 2004;128:245-53. Go to original source... Go to PubMed...
  13. Sonveaux P, Martinive P, DeWewer J, et al. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitrix oxide-mediated angiogenesis. Cir Res 2004;95: 154-61. Go to original source... Go to PubMed...
  14. Hocht E, Kahnert H, Guan K, et al. Cellular repopulation of myocardial infarction in patients with sex-mismatched heart transplantation. Eur Heart J 2004;25: 749-58. Go to original source... Go to PubMed...
  15. Cleland JGF, Freemantle N, Coletta AP, Clark AL. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail 2005;8: 105-10. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.